agilon health (NYSE:AGL) Trading Up 5.7% – Should You Buy?

agilon health, inc. (NYSE:AGLGet Free Report) traded up 5.7% during mid-day trading on Monday . The company traded as high as $2.24 and last traded at $2.21. 854,352 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 4,907,579 shares. The stock had previously closed at $2.09.

Analyst Ratings Changes

A number of brokerages have commented on AGL. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research note on Wednesday, October 2nd. Stifel Nicolaus cut their price target on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Evercore ISI dropped their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Finally, Barclays reduced their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, agilon health has an average rating of “Hold” and a consensus target price of $6.05.

Read Our Latest Report on agilon health

agilon health Stock Performance

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock’s 50-day moving average is $2.66 and its 200-day moving average is $4.58. The stock has a market cap of $918.80 million, a price-to-earnings ratio of -2.33 and a beta of 0.51.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the business posted ($0.06) earnings per share. On average, analysts expect that agilon health, inc. will post -0.47 EPS for the current year.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of AGL. CWM LLC boosted its holdings in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares in the last quarter. Simplicity Wealth LLC grew its stake in shares of agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after acquiring an additional 15,515 shares during the period. J.Safra Asset Management Corp raised its holdings in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the period. Nisa Investment Advisors LLC bought a new position in shares of agilon health in the second quarter valued at approximately $60,000. Finally, Neo Ivy Capital Management bought a new position in shares of agilon health in the second quarter valued at approximately $1,006,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.